Editor’s Note: The deadline for online media registration is Nov. 9. After that date, media must register on-site in the press room located in the Colorado Convention Center. All press must provide press credentials to attend this meeting.
For media registration or inquiries, please contact Kaitlin Baumer at [email protected] or 703-248-4772.
Newswise — WHO: American Association of Pharmaceutical Scientists (AAPS) WHAT: The 2016 AAPS Annual Meeting and Exposition will bring together more than 6,500 scientists, business leaders, government officials and students from around the world to share and learn the latest scientific advances and industry developments.
Along with the traditional in-depth examination of critical issues, the five-day event will feature broad based programming on four themes: • Advancing Product Development through Novel Technology: Material Science, Engineering and Analytical Methodology• Making New Delivery Modalities a Reality: Peptides, Proteins and Conjugates• Enhancing Patient Lives through Accelerated Drug Development• Paving the Way for Precision Medicine: Innovation and ImplementationThe meeting features nearly 245 programming sessions, including more than 65 symposia and roundtables.
WHEN: November 13–17, 2016 WHERE: Colorado Convention Center700 14th StreetDenver, CO 80202
SPEAKERS: The keynote and plenary speakers will explore some of today’s most innovative health care technologies, and how these technologies are being applied in current clinical practice to better the lives of patients.• Daniel A. Fletcher, Ph.D., is the Chatterjee Professor of Bioengineering and Biophysics at the University of California at Berkeley and chair of the Department of Bioengineering, where his laboratory develops diagnostic medical devices and investigates biophysical mechanisms of disease. Fletcher cofounded the medical device company CellScope, Inc., served as a White House Fellow in the Office of Science and Technology Policy, is an elected Fellow of the American Institute for Medical and Biological Engineering, and was named one of Foreign Policy’s 100 Leading Global Thinkers of 2015.• Frederick Balagadde, Ph.D., is a principal investigator at K-RITH (Durban, South Africa), the first microfluidics research facility in Africa. There he is developing microfluidic systems to increase access to affordable health care. He received the prestigious TEDGlobal fellowship in 2009 and became a TED Senior Fellow in 2010. Balagadde received his doctorate in applied physics from California Institute of Technology, where he invented the microchemostat: a microfluidic chip for propagating bacterial cells in perpetuity. His work has been featured on National Public Radio and published in leading scientific journals.• James Olson, M.D., Ph.D., is a physician scientist who cares for children with brain tumors and discovers/develops new cancer therapies. His lab's work led to five national clinical trials, of which he leads a phase 3 trial through the Children’s Oncology Group. His team invented chlorotoxin-based tumor paint, which led to the clinical candidate BLZ-100, developed by Blaze Bioscience and currently in human trials. Olson is the founder of Presage Biosciences and Blaze Bioscience: The Tumor Paint Company. He authored Clinical Pharmacology Made Ridiculously Simple, which has been the most used pharmacology board review book for 23 years.• Susan Hershenson, Ph.D., is the deputy director, Chemistry, Manufacturing, and Controls at the Bill and Melinda Gates Foundation. There she works closely with the Foundation’s strategy teams and partners to provide technical expertise and strategic guidance for the therapeutics projects. Prior to joining the foundation, she founded Pharmaceutical Transformations LLC, a consulting service for the pharmaceutical, biotechnology, drug delivery, and related industries.
For the most up-to-date program information, visit the 2016 AAPS Annual Meeting and Exposition Program.
# # #
About AAPS: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Visit www.aaps.org and follow us on Facebook and Twitter @AAPSComms; official Twitter hashtag for the meeting is: #AAPS2016.
RSS